14 Sep, 2020 RNAi Roundtable: Givosiran, for the Treatment of Acute Hepatic Porphyria
Posted at 15:51h
in Capella
On September 14, 2020, we hosted an online RNAi Roundtable to review progress with givosiran, an RNAi therapeutic for the treatment of acute hepatic porphyria.
Access the replay
View the presentation
Akin Akinc, Ph.D.
Vice President & General Manager, Givosiran
Gail Hartigan
Senior Director, U.S. Business Lead
Amy Simon, M.D.
Vice President, Clinical Research
